Clinical Trial Update: Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI). [EARLY_Phase 1]

View source ↗

Summary

An early-phase pilot study evaluating whether contrast-enhanced ultrasound can predict treatment response to chemotherapy plus immune checkpoint inhibitors in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Breast Cancer, Contrast Enhanced Ultrasound | EARLY_Phase 1 | Status: WITHDRAWN